The differential effect of Toxoplasma gondii infection on the stability of BCL2-family members involves multiple activities

Frontiers in Microbiology

Volumn 2, Issue JAN, 2011, Pages

  Carmen, John Cherrington ^a,b   Sinai, Anthony Peter ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b University of Wisconsin Health   (United States)

Author keywords

Apoptosis; BCL2; NF B; Protease inhibition; Proteasome; Toxoplasma gondii

Indexed keywords

EID: 84857445103     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2011.00001     Document Type: Article

References (64)

1. Abu-Qare, A. W., and Abou-Donia, M. B. (2001). Biomarkers of apoptosis: release of cytochrome c, activation of caspase-3, induction of 8-hydroxy-2′-deoxyguanosine, increased 3-nitrotyrosine, and alteration of p53 gene. J. Toxicol. Environ. Health B Crit. Rev. 4, 313-332.
2. Ahn, H. J., Song, K. J., Son, E. S., Shin, J. C., and Nam, H. W. (2001). Protease activity and host cell binding of the 42-kDa rhoptry protein from Toxoplasma gondii after secretion. Biochem. Biophys. Res. Commun. 287, 630-635.
3. Baliga, B., and Kumar, S. (2003). Apaf-1/ cytochrome c apoptosome: an essential initiator of caspase activation or just a sideshow? Cell Death Differ. 10, 16-18.
4. Barry, D. P., and Beaman, B. L. (2006). Modulation of eukaryotic cell apoptosis by members of the bacterial order Actinomycetales. Apoptosis 11, 1695-1707.
5. Boothroyd, J. C. (2009). Toxoplasma gondii: 25 years and 25 major advances for the field. Int. J. Parasitol. 39, 935-946.
6. Boyle, J. P., and Radke, J. R. (2009). A history of studies that examine the interactions of toxoplasma with its host cell: emphasis on in vitro models. Int. J. Parasitol. 39, 903-914.
7. Bradley, P. J., Ward, C., Cheng, S. J., Alexander,D. L., Coller, S., Coombs, G. H., Dunn, J. D., Ferguson, D. J., Sanderson, S. J., Wastling, J. M., and Boothroyd, J. C. (2005). Proteomic analysis of rhoptry organelles reveals many novel constituents for hostparasite interactions in Toxoplasma gondii. J. Biol. Chem. 280, 34245-34258.
8. Brunelle, J. K., and Letai, A. (2009). Control of mitochondrial apoptosis by the Bcl-2 family. J. Cell. Sci. 122, 437-441.
9. Byrne, G. I., and Ojcius, D. M. (2004). Chlamydia and apoptosis: life and death decisions of an intracellular pathogen. Nat. Rev. Microbiol. 2, 802-808.
10. Carmen, J. C., Hardi, L., and Sinai, A. P. (2006). Toxoplasma gondii inhibits ultraviolet light-induced apoptosis through multiple interactions with the mitochondrion-dependent programmed cell death pathway. Cell. Microbiol. 8, 301-315.
11. Carmen, J. C., and Sinai, A. P. (2007). Suicide prevention: disruption of apoptotic pathways by protozoan parasites. Mol. Microbiol. 64, 904-916.
12. Carmen, J. C., Southard, R. C., and Sinai, A. P. (2008). The complexity of signaling in host-pathogen interactions revealed by the Toxoplasma gondii-dependent modulation of JNK phosphorylation. Exp. Cell Res. 314, 3724-3736.
13. Cuppari, A. F., Sanchez, V., Ledesma, B., Frank, F. M., Goldman, A., Angel, S. O., and Martin, V. (2008). Toxoplasma gondii protease inhibitor-1 (TgPI-1) is a novel vaccine candidate against toxo-plasmosis. Vaccine 26, 5040-5045.
14. Dechend, R., Maass, M., Gieffers, J., Dietz, R., Scheidereit, C., Leutz, A., and Gulba, D. C. (1999). Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappaB and induces tissue factor and PAI-1 expression: a potential link to accelerated arteriosclerosis. Circulation 100, 1369-1373.
15. Donald, R. G., and Roos, D. S. (1998). Gene knock-outs and allelic replacements in Toxoplasma gondii: HXGPRT as a selectable marker for hit-and-run mutagenesis. Mol. Biochem. Parasitol. 91, 295-305.
16. Dong, F., Pirbhai, M., Xiao, Y., Zhong, Y., Wu, Y., and Zhong, G. (2005). Degradation of the proapoptotic proteins Bik, Puma, and Bim with Bcl-2 domain 3 homology in Chlamydia trachomatis-infected cells. Infect. Immun. 73, 1861-1864.
17. Dong, F., Su, H., Huang, Y., Zhong, Y., and Zhong, G. (2004). Cleavage of host keratin 8 by a Chlamydia-secreted protease. Infect. Immun. 72, 3863-3868.
18. Faherty, C. S., and Maurelli, A. T. (2008). Staying alive: bacterial inhibition of apoptosis during infection. Trends Microbiol. 16, 173-180.
19. Fischer, S. F., Vier, J., Kirschnek, S., Klos, A., Hess, S., Ying, S., and Hacker, G. (2004). Chlamydia inhibit host cell apoptosis by degradation of proapoptotic BH3-only proteins. J. Exp. Med. 200, 905-916.
20. Fox, B. A., Ristuccia, J. G., Gigley, J. P., and Bzik, D. J. (2009). Efficient gene replacements in Toxoplasma gondii strains deficient for nonhomologous end joining. Eukaryotic Cell 8, 520-529.
21. Frydrych, I., and Mlejnek, P. (2008). Serine protease inhibitors N-alpha-tosyl-llysinyl-chloromethylketone (TLCK) and N-tosyl-l-phenylalaninyl-chloromethylketone (TPCK) are potent inhibitors of activated caspase proteases. J. Cell. Biochem. 103, 1646-1656.
22. Galluzzi, L., Brenner, C., Morselli, E., Touat, Z., and Kroemer, G. (2008). Viral control of mitochondrial apoptosis. PLoS Pathog. 4, e1000018. doi: 10.1371/journal.ppat.1000018
23. Gapuzan, M. E., Schmah, O., Pollock, A. D., Hoffmann, A., and Gilmore, T. D. (2005). Immortalized fibroblasts from NF-kappaB RelA knockout mice show phenotypic heterogeneity and maintain increased sensitivity to tumor necrosis factor alpha after transformation by v-Ras. Oncogene 24, 6574-6583.
24. Gilbert, L. A., Ravindran, S., Turetzky, J. M., Boothroyd, J. C., and Bradley. P. J. (2007). Toxoplasma gondii targets a protein phosphatase 2C to the nuclei of infected host cells. Eukaryotic Cell 6, 73-83.
25. Giuliano, M., A. D'Anneo, A. De Blasio, Vento, R., and Tesoriere, G. (2003). Apoptosis meets proteasome, an invaluable therapeutic target of anticancer drugs. Ital. J. Biochem. 52, 112-121.
26. Goebel, S., Gross, U., and Luder, C. G. (2001). Inhibition of host cell apoptosis by Toxoplasma gondii is accompanied by reduced activation of the caspase cascade and alterations of poly(ADP-ribose) polymerase expression. J. Cell. Sci. 114, 3495-3505.
27. Gogvadze, V., Orrenius, S., and Zhivotovsky, B. (2006). Multiple pathways of cytochrome c release from mitochondria in apoptosis. Biochim. Biophys. Acta 1757, 639-647.
28. Goldstein, J. C., Waterhouse, N. J., Juin, P., Evan, G. I., and Green, D. R. (2000). The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant. Nat. Cell Biol. 2, 156-162.
29. Hasnain, S. E., Begum, R., Ramaiah, K. V., Sahdev, S., Shajil, E. M., Taneja, T. K., Mohan, M., Athar, M., Sah, N. K., and Krishnaveni, M. (2003). Host-pathogen interactions during apoptosis. J. Biosci. 28, 349-358.
30. Hernandez, A. A., and Roush, W. R. (2002). Recent advances in the synthesis, design and selection of cysteine protease inhibitors. Curr. Opin. Chem. Biol. 6, 459-465.
31. Hippe, D., Gais, A., Gross, U., and Luder, C. G. (2009a). Modulation of caspase activation by Toxoplasma gondii. Methods Mol. Biol. 470, 275-288.
32. Hippe, D., Weber, A., Zhou, L., Chang, D. C., Hacker, G., and Luder, C. G. (2009b). Toxoplasma gondii infection confers resistance against BimS-induced apoptosis by preventing the activation and mitochondrial targeting of pro-apoptotic bax. J. Cell. Sci. 122, 3511-3521.
33. Hoff, H., Zhang, H., and Sell, C. (2004). Protein degradation via the proteasome. Methods Mol. Biol. 285, 79-92.
34. Huynh, M. H., and Carruthers, V. B. (2009). Tagging of endogenous genes in a Toxoplasma gondii strain lacking Ku80. Eukaryotic Cell 8, 530-539.
35. Jerczynska, H., and Pawlowska, Z. (2009). Intracellular signaling pathways involved in inhibition of PAI-1 expression by CNP in endothelial cells. Regul. Pept. 155, 150-155.
36. Karin, M., and Lin, A. (2002). NF-kappaB at the crossroads of life and death. Nat. Immunol. 3, 221-227.
37. Kurinov, I. V., and Harrison, R. W. (1996). Two crystal structures of the leupep-tin-trypsin complex. Protein Sci. 5, 752-758.
38. Lalier, L., Cartron, P. F., Juin, P., Nedelkina, S., Manon, S., Bechinger, B., and Vallette, F. M. (2007). Bax activation and mitochondrial insertion during apoptosis. Apoptosis 12, 887-896.
39. Law, R. H., Zhang, Q., McGowan, S., Buckle, A. M., Silverman, G. A., Wong, W., Rosado, C. J., Langendorf, C. G., Pike, R. N., Bird, P. I., and Whisstock, J. C. (2006). An overview of the serpin superfamily. Genome Biol. 7, 216.
40. Lee, D. H., and Goldberg, A. L. (1998). Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol. 8, 397-403.
41. Lindvall, M. K. (2002). Molecular modeling in cysteine protease inhibitor design. Curr. Pharm. Des. 8, 1673-1681.
42. Liston, P., Fong, W. G., and Korneluk. R. G. (2003). The inhibitors of apoptosis: there is more to life than Bcl2. Oncogene 22, 8568-8580.
43. Marsden, V. S., and Strasser, A. (2003). Control of apoptosis in the immune system: Bcl-2, BH3-only proteins and more. Annu. Rev. Immunol. 21, 71-105.
44. Molestina, R. E., Payne, T. M., Coppens, I., and Sinai, A. P. (2003). Activation of NF-kappaB by Toxoplasma gondii correlates with increased expression of antiapoptotic genes and localization of phosphorylated IkappaB to the parasitophorous vacuole membrane. J. Cell. Sci. 116, 4359-4371.
45. Molestina, R. E., and Sinai, A. P. (2005a). Detection of a novel parasite kinase activity at the Toxoplasma gondii parasitophorous vacuole membrane capable of phosphorylating host IkappaBalpha. Cell. Microbiol. 7, 351-362.
46. Molestina, R. E., and Sinai, A. P. (2005b). Host and parasite-derived IKK activities direct distinct temporal phases of NF-{kappa}B activation and target gene expression following Toxoplasma gondii infection. J. Cell. Sci. 118, 5785-5796.
47. Morris, M. T., Coppin, A., Tomavo, S., and Carruthers, V. B. (2002). Functional analysis of Toxoplasma gondii protease inhibitor 1. J. Biol. Chem. 277, 45259-45266.
48. Mutoh, M., Niho, N., Komiya, M., Takahashi, M., Ohtsubo, R., Nakatogawa, K., Ueda, K., Sugimura, T., and Wakabayashi, K. (2008). Plasminogen activator inhibitor-1 (Pai-1) blockers suppress intestinal polyp formation in Min mice. Carcinogenesis 29, 824-829.
49. Otlewski, J., Jelen, F., Zakrzewska, M., and Oleksy, A. (2005). The many faces of protease-protein inhibitor interaction. EMBO J. 24, 1303-1310.
50. Papa, S., Bubici, C., Zazzeroni, F., Pham, C. G., Kuntzen, C., Knabb, J. R., Dean, K., and Franzoso, G. (2006). The NF-kappaB-mediated control of the JNK cascade in the antagonism of programmed cell death in health and disease. Cell Death Differ. 13, 712-729.
51. Payne, T. M., Molestina, R. E., and Sinai, A. P. (2003). Inhibition of caspase activation and a requirement for NF-kappaB function in the Toxoplasma gondii-mediated blockade of host apoptosis. J. Cell. Sci. 116, 4345-4358.
52. Peixoto, L., Chen, F., Harb, O. S., Davis, P. H., Beiting, D. P., Brownback, C. S., Ouloguem, D., and Roos, D. S. (2010). Integrative genomic approaches highlight a family of parasite-specific kinases that regulate host responses. Cell Host Microbe 8, 208-218.
53. Pinkoski, M. J., Waterhouse, N. J., and Green, D. R. (2006). Mitochondria, apoptosis and autoimmunity. Curr. Dir. Autoimmun. 9, 55-73.
54. Scorrano, L., and Korsmeyer, S. J. (2003). Mechanisms of cytochrome c release by proapoptotic BCL-2 family members. Carmen and Sinai T. gondii manipulation of BCL2-family proteins Biochem. Biophys. Res. Commun. 304, 437-444.
55. Sinai, A. P., and Joiner, K. A. (1997). Safe haven: the cell biology of non-fusogenic pathogen vacuoles. Annu. Rev. Microbiol. 51, 415-462.
56. Tenter, A. M., Heckeroth, A. R., and Weiss, L. M. (2000). Toxoplasma gondii: from animals to humans. Int. J. Parasitol. 30, 1217-1258.
57. Teo, C. F., Zhou, X. W., Bogyo, M., and Carruthers, V. B. (2007). Cysteine protease inhibitors block Toxoplasma gondii microneme secretion and cell invasion. Antimicrob. Agents Chemother. 51, 679-688.
58. Thomadaki, H., and Scorilas, A. (2008). Molecular profile of the BCL2 family of the apoptosis related genes in breast cancer cells after treatment with cytotoxic/cytostatic drugs. Connect. Tissue Res. 49, 261-264.
59. *. Annu. Rev. Genet. 43, 95-118.
60. Wu, X., and Deng, Y. (2002). Bax and BH3-domain-only proteins in p53-mediated apoptosis. Front. Biosci. 7:d151-d156.
61. Wullaert, A., Heyninck, K., and Beyaert, R. (2006). Mechanisms of crosstalk between TNF-induced NF-kappaB and JNK activation in hepatocytes. Biochem. Pharmacol. 72, 1090-1101.
62. Ying, S., Seiffert, B. M., Hacker, G., and Fischer. S. F. (2005). Broad degradation of proapoptotic proteins with the conserved Bcl-2 homology domain 3 during infection with Chlamydia trachomatis. Infect. Immun. 73, 1399-1403.
63. Zhong, G., Fan, P., Ji, H., Dong, F., and Huang, Y. (2001). Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J. Exp. Med. 193, 935-942.
64. Zou, H., Li, Y., Liu, X., and Wang, X. (1999). An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J. Biol. Chem. 274, 11549-11556.